HomeCompareNPTVF vs JNJ

NPTVF vs JNJ: Dividend Comparison 2026

NPTVF yields 1.00% · JNJ yields 2.13%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 JNJ wins by $6.5K in total portfolio value· pulled ahead in Year 7
10 years
NPTVF
NPTVF
● Live price
1.00%
Share price
$21.76
Annual div
$0.22
5Y div CAGR
19.3%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$23.7K
Annual income
$681.85
Full NPTVF calculator →
JNJ
Johnson & Johnson
● Live price
2.13%
Share price
$244.44
Annual div
$5.20
5Y div CAGR
28%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$30.3K
Annual income
$4,689.40
Full JNJ calculator →

Portfolio growth — NPTVF vs JNJ

📍 JNJ pulled ahead of the other in Year 7

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodNPTVFJNJ
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, NPTVF + JNJ cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
NPTVF pays
JNJ pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

NPTVF
Annual income on $10K today (after 15% tax)
$84.65/yr
After 10yr DRIP, annual income (after tax)
$579.57/yr
JNJ
Annual income on $10K today (after 15% tax)
$180.82/yr
After 10yr DRIP, annual income (after tax)
$3,985.99/yr
At 15% tax rate, JNJ beats the other by $3,406.42/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of NPTVF + JNJ for your $10,000?

NPTVF: 50%JNJ: 50%
100% JNJ50/50100% NPTVF
Portfolio after 10yr
$27.0K
Annual income
$2,685.62/yr
Blended yield
9.94%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

NPTVF
No analyst data
Altman Z
3.7
Piotroski
6/9
JNJ
Analyst Ratings
20
Buy
17
Hold
3
Sell
Consensus: Buy
Price Target
$228.73
-6.4% upside vs current
Range: $190.00 — $265.00
Altman Z
5.2
Piotroski
4/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

NPTVF buys
0
JNJ buys
8
PoliticianChamberTickerTypeAmountDate
Thomas H. Kean🏢 House$JNJ▼ Sell$15,001 - $50,0002026-01-23
Julie Johnson🏢 House$JNJ▼ Sell$1,001 - $15,0002025-12-18
Lloyd Doggett🏢 House$JNJ▲ Buy$1,001 - $15,0002025-12-09
Thomas H. Kean🏢 House$JNJ▼ Sell$15,001 - $50,0002025-11-20
Julie Johnson🏢 House$JNJ▼ Sell$1,001 - $15,0002025-11-13
Rich McCormick🏢 House$JNJ▲ Buy$1,001 - $15,0002025-11-05
Ro Khanna🏢 House$JNJ▲ Buy$1,001 - $15,0002025-10-30
Ro Khanna🏢 House$JNJ▲ Buy$1,001 - $15,0002025-10-30
Ro Khanna🏢 House$JNJ▲ Buy$1,001 - $15,0002025-10-30
Jared Moskowitz🏢 House$JNJ▼ Sell$1,001 - $15,0002025-10-10
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricNPTVFJNJ
Forward yield1.00%2.13%
Annual dividend / share$0.22$5.20
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR19.3%28%
Portfolio after 10y$23.7K$30.3K
Annual income after 10y$681.85$4,689.40
Total dividends collected$3.3K$15.4K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: NPTVF vs JNJ ($10,000, DRIP)

YearNPTVF PortfolioNPTVF Income/yrJNJ PortfolioJNJ Income/yrGap
1$10,819$118.81$10,592$272.30+$227.00NPTVF
2$11,719$143.31$11,289$357.73+$430.00NPTVF
3$12,713$173.09$12,123$472.89+$590.00NPTVF
4$13,812$209.34$13,141$629.86+$671.00NPTVF
5$15,033$253.59$14,408$846.81+$625.00NPTVF
6$16,393$307.72$16,021$1,151.60+$372.00NPTVF
7← crossover$17,914$374.13$18,122$1,588.22$208.00JNJ
8$19,624$455.86$20,930$2,228.20$1.3KJNJ
9$21,554$556.78$24,792$3,191.91$3.2KJNJ
10$23,745$681.85$30,274$4,689.40$6.5KJNJ

NPTVF vs JNJ: Complete Analysis 2026

NPTVFStock

Nippon Television Holdings, Inc. operates as a media and content company in Japan. The company engages in the production of broadcasting programs; digital broadcasting; technical production related to studios, live broadcasting, master technology, EJ news gathering, editing, postproduction, etc.; and programming, content production, closed captioning, library, etc. It is also involved in sporting and various NTV events; the management of NTV school; art design, and lighting and sound effects; design of sets, flip charts, and TV graphics; production of pamphlets, posters, etc.; intellectual property management; management of music publishing, CD master, and merchandising rights; production CDs and DVDs; rental of recording studios; and operation of fitness clubs, insurance agencies, and museums. In addition, the company engages in the production and construction of exhibitions, sales promotion events, international sports events, theme parks, amusement facilities, national ceremonies, etc.; production of program-related merchandise goods; commercial building maintenance; race track, concerts, and events management; ICT, development of apps for business, web development, video streaming, infrastructure solutions, and advertising; shopping portal sites management; production of animation, TV programs, commercial films, graphic designs, illustrations, characters, social games, and other content; copyright management; and internet content streaming. Further, it engages in the provision of software and systems for VOD and live streaming platforms and players; news gathering, reporting, and production of information, sports programs, etc.; 3D computer graphics; services to program and technology production, clerical, and management duties; e-commerce, esports, and talent production agency businesses; contractual production of programs for broadcasters; and influencers network and production business. The company was incorporated in 1952 and is based in Tokyo, Japan.

Full NPTVF Calculator →

JNJHealthcare

Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.

Full JNJ Calculator →
📬

Get this NPTVF vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

NPTVF vs SCHDNPTVF vs JEPINPTVF vs ONPTVF vs KONPTVF vs MAINNPTVF vs ABBVNPTVF vs MRKNPTVF vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.